Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.
Marco Rovaris(San Raffaele University of Rome), Giancarlo Comi(Vita-Salute San Raffaele University), Giuseppe Santuccio(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Giuseppe Iannucci(Vita-Salute San Raffaele University), Francesca Possa(IRCCS Ospedale San Raffaele), L. Minicucci(San Raffaele University of Rome)
PubMed
February 1, 2000
Cited by 199
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k